Abdallah, Nadine H. http://orcid.org/0000-0001-9195-1589
Nagayama, Hiroki
Takahashi, Naoki
Gonsalves, Wilson
Fonder, Amie
Dispenzieri, Angela http://orcid.org/0000-0001-8780-9512
Dingli, David http://orcid.org/0000-0001-7477-3004
Buadi, Francis K. http://orcid.org/0000-0003-3214-0203
Lacy, Martha Q.
Hobbs, Miriam
Gertz, Morie A. http://orcid.org/0000-0002-3853-5196
Binder, Moritz http://orcid.org/0000-0001-9014-9658
Kapoor, Prashant http://orcid.org/0000-0002-4342-364X
Warsame, Rahma
Hayman, Suzanne R.
Kourelis, Taxiarchis http://orcid.org/0000-0001-8573-9434
Hwa, Yi L.
Lin, Yi http://orcid.org/0000-0002-1556-6416
Kyle, Robert A.
Rajkumar, S. Vincent http://orcid.org/0000-0002-5862-1833
Broski, Stephen M.
Kumar, Shaji K. http://orcid.org/0000-0001-5392-9284
Article History
Received: 14 March 2023
Revised: 13 August 2023
Accepted: 24 October 2023
First Online: 12 December 2023
Competing interests
: AD received research funding from Celgene, Millennium Pharmaceuticals, Pfizer, and Janssen and received a travel grant from Pfizer. MAG served as a consultant for Millennium Pharmaceuticals and received honoraria from Celgene, Millennium Pharmaceuticals, Onyx Pharmaceuticals, Novartis, GlaxoSmithKline, Prothena, Ionis Pharmaceuticals, and Amgen. MQL received research funding from Celgene. PK received research funding from Takeda Pharmaceuticals, Celgene, and Amgen. SKK served as a consultant for Celgene, Millennium Pharmaceuticals, Onyx Pharmaceuticals, Janssen, and Bristol-Myers Squibb and received research funding from Celgene, Millennium Pharmaceuticals, Novartis, Onyx Pharmaceuticals, AbbVie, Janssen, and Bristol-Myers Squibb. The remaining authors declare no competing interests.